While the number of prescription fills for GLP-1 receptor agonists has continued to increase, health Insurance coverage for ...

DUBLIN--(BUSINESS WIRE)--The "Liraglutide and Semaglutide Market by Type, by Route of Administration, by Application, by Distribution Channel, and by Region" report has been added to ...

There are early and suggestive data that GLP-1 drugs reduce alcohol cravings. A large cohort of people with alcohol use ...

Hims & Hers Health ( HIMS -15.90%) has been a top healthcare stock to own over the past five years, soaring by around 350% ...

Researchers found that GLP-1 receptor agonists (GLP-1RAs) significantly reduce the risk of several blood cancers in type 2 ...

SAN DIEGO -- Two retrospective studies hinted at potential negative effects of GLP-1 receptor agonists for patients requiring ...

liraglutide, semaglutide, and tirzepatide. Estimated global 2024 revenue of these three drugs is~$30 billion, compared to just $300 million in 2018, an increase of 100x or 10,000%. To support the ...

Stanford Medicine researchers have identified a promising, naturally occurring molecule that could help people lose ...

The U.S. Food and Drug Administration said on Monday it will not take action against compounding pharmacies making copies of ...